Novavax Inc (STU:NVV1)
€ 13.352 1.6 (13.61%) Market Cap: 1.95 Bil Enterprise Value: 1.72 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 72/100

Q4 2021 Novavax Inc Earnings Call Transcript

Feb 28, 2022 / 09:30PM GMT
Release Date Price: €71.2 (-0.75%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Novavax Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights Conference Call. (Operator Instructions) Please also be advised that today's conference call is being recorded. (Operator Instructions) I would now like to hand the conference call over to your speaker today, Silvia Taylor. You may begin.

Silvia Taylor
Novavax, Inc. - SVP of Global Corporate Affairs & IR

Good afternoon, and thank you all for joining us today to discuss our fourth quarter and full year 2021 operational highlights and financial results. A press release announcing our results is currently available on our website at novavax.com, and an audio archive of this conference call will be available on our website later today.

Before we begin with prepared remarks, I need to remind you that we will be making forward-looking statements during this teleconference, which are based on our current expectations and beliefs. For example, statements relating to future financial or business

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot